Online Program Home
My Program

Abstract Details

Activity Number: 301 - SPEED: Statistics for Biopharmaceutical Studies
Type: Contributed
Date/Time: Tuesday, July 31, 2018 : 8:30 AM to 10:20 AM
Sponsor: Biopharmaceutical Section
Abstract #328373 Presentation
Title: STEPDOWN TESTING PROCEDURES for DOSE FINDING STUDY with ADAPTIVE DESIGN
Author(s): Gang Jia*
Companies: Merck & Co.
Keywords: Dose study; adaptive study; phase 2 study; multiple testing
Abstract:

The problem of identifying the lowest effective drug dose and/or the highest safe dose is often an important issue in a drug efficacy study. Stepdown testing procedure is a widely used approach in this area. Under the assumption of a monotone mean configuration, the stepdown testing procedure is particularly powerful and easy to perform. One common shortcoming of the previous research is that the proposed testing procedures have implicitly assumed that the dose study data are randomly collected from the probability distributions. In a clinical dose study with adaptive design, this assumption is not correct because the data collected are not totally random samples. It is necessary to tailor stepwise testing procedures for non-random samples in order to draw valid statistical inference. A simulation-based approach is proposed to address the issue.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2018 program